| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |